title: Gα12 activation in podocytes leads to cumulative changes in glomerular collagen expression, proteinuria and glomerulosclerosis.
abstract: Glomerulosclerosis is a common pathological finding that often progresses to renal failure. The mechanisms of chronic kidney disease progression are not well defined, but may include activation of numerous vasoactive and inflammatory pathways. We hypothesized that podocytes are susceptible to filtered plasma components, including hormones and growth factors that stimulate signaling pathways leading to glomerulosclerosis. Gα12 couples to numerous G-protein-coupled receptors (GPCRs) and regulates multiple epithelial responses, including proliferation, apoptosis, permeability and the actin cytoskeleton. Herein, we report that genetic activation of Gα12 in podocytes leads to time-dependent increases in proteinuria and glomerulosclerosis. To mimic activation of Gα12 pathways, constitutively active Gα12 (QL) was conditionally expressed in podocytes using Nphs2-Cre and LacZ/floxed QLα12 transgenic mice. Some QLα12(LacZ+/Cre+) mice developed proteinuria at 4-6 months, and most were proteinuric by 12 months. Proteinuria increased with age, and by 12-14 months, many demonstrated glomerulosclerosis with ultrastructural changes, including foot process fusion and both mesangial and subendothelial deposits. QLα12(LacZ+/Cre+) mice showed no changes in podocyte number, apoptosis, proliferation or Rho/Src activation. Real-time PCR revealed no significant changes in Nphs1, Nphs2, Cd2ap or Trpc6 expression, but Col4a2 message was increased in younger and older mice, while Col4a5 was decreased in older mice. Confocal microscopy revealed disordered collagen IVα1/2 staining in older mice and loss of α5 without changes in other collagen IV subunits. Taken together, these studies suggest that Gα12 activation promotes glomerular injury without podocyte depletion through a novel mechanism regulating collagen (α)IV expression, and supports the notion that glomerular damage may accrue through persistent GPCR activation in podocytes.
authors.affiliation: Renal Division, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
authors.forename: Ilene
authors.initials: I
authors.lastname: Boucher
authors.forename: Wanfeng
authors.initials: W
authors.lastname: Yu
authors.forename: Sarah
authors.initials: S
authors.lastname: Beaudry
authors.forename: Hideyuki
authors.initials: H
authors.lastname: Negoro
authors.forename: Mei
authors.initials: M
authors.lastname: Tran
authors.forename: Martin R
authors.initials: MR
authors.lastname: Pollak
authors.forename: Joel M
authors.initials: JM
authors.lastname: Henderson
authors.forename: Bradley M
authors.initials: BM
authors.lastname: Denker
mesh_terms: D000209:Acute-Phase Proteins / Q000378:metabolism; D000367:Age Factors; D000818:Animals; D002478:Cells, Cultured; D024141:Collagen Type IV / Q000378:metabolism*; D005260:Female; D044365:GTP-Binding Protein alpha Subunits, G12-G13 / Q000235:genetics / Q000378:metabolism*; D016391:Genes, src / Q000502:physiology; D005923:Glomerulosclerosis, Focal Segmental / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D007678:Kidney Glomerulus / Q000378:metabolism / Q000473:pathology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D018613:Microscopy, Confocal; D008854:Microscopy, Electron; D050199:Podocytes / Q000378:metabolism* / Q000473:pathology; D011507:Proteinuria / Q000378:metabolism* / Q000473:pathology; D043562:Receptors, G-Protein-Coupled / Q000378:metabolism*
chemical_list: D000209:Acute-Phase Proteins; D024141:Collagen Type IV; D043562:Receptors, G-Protein-Coupled; C010781:acute-phase protein rho; D044365:GTP-Binding Protein alpha Subunits, G12-G13